Compound Information
Test on : RBC, Metz
Compound Name
RBC, Metz : VX-702
Inchikey
Same : FYSRKRZDBHOFAY-N
RBC, Metz : FYSRKRZDBHOFAY-UHFFFAOYSA-N
ChemSpider
RBC, Metz : 8516613
Pubchem CID
RBC, Metz : 10341154
ChEMBL
RBC, Metz : CHEMBL1090090
|
DRx |
RBC |
Metz |
Millipore |
GPCR |
| bioactivity |
Kd (nM) |
Remain Activity (%) |
Ki (nM) |
Remain Activity (%) |
Inhibition (%) |
| active criteria |
<3000nM |
<50% |
<1000nM |
<50% |
>50% |
AGC
AGC - PDK1
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| PDK1 | inactive (87.4%) | - |
AGC - Akt
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| AKT1 | inactive (84.72%) | - |
| AKT2 | inactive (118.28%) | - |
| AKT3 | inactive (86.24%) | - |
AGC - DMPK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| DMPK1 | inactive (103.72%) | - |
| MRCKa | inactive (93.8%) | - |
| MRCKb | inactive (96.52%) | - |
| ROCK1 | inactive (107.81%) | inactive (2511.89nM) |
| ROCK2 | inactive (97.66%) | - |
AGC - GRK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| BARK1 | inactive (99.03%) | - |
| BARK2 | inactive (98.14%) | - |
| GPRK4 | inactive (90.74%) | - |
| GPRK5 | inactive (103.21%) | - |
| GPRK6 | inactive (97.05%) | - |
| GPRK7 | inactive (108.5%) | - |
AGC - RSK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| MSK1 | inactive (92.85%) | - |
| MSK2 | inactive (99.01%) | - |
| p70S6K | inactive (100.13%) | - |
| p70S6Kb | inactive (100.08%) | - |
| RSK2 | inactive (99.84%) | - |
| RSK4 | inactive (101.25%) | - |
| RSK1 | inactive (108.84%) | - |
| RSK3 | inactive (97.53%) | - |
AGC - PKA
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| PKACg | inactive (109.18%) | - |
| PRKX | inactive (123.07%) | - |
| PKACa | inactive (100.84%) | - |
AGC - PKC
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| PKCa | inactive (85.96%) | - |
| PKCd | inactive (103.55%) | - |
| PKCe | inactive (100.78%) | - |
| PKCh | inactive (112.44%) | - |
| PKCg | inactive (91.25%) | - |
| PKCi | inactive (99.14%) | - |
| PKCt | inactive (85.11%) | - |
| PKCz | inactive (89.94%) | - |
| PKCb | inactive (94.64%) | - |
AGC - PKG
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| PKG2 | inactive (98.09%) | - |
| PKG1 | inactive (88.06%) | - |
AGC - PKN
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| PKN1 | inactive (101.2%) | - |
| PKN2 | inactive (99.71%) | - |
AGC - SGK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| SGK1 | inactive (121.07%) | - |
| SGK2 | inactive (106.76%) | - |
| SGK3 | inactive (99.92%) | - |
AGC - NDR
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| NDR1 | inactive (101.19%) | - |
TK
TK - Abl
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| ABL1 | inactive (99.67%) | - |
| ABL2 | inactive (100%) | - |
TK - Ack
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| ACK | inactive (96.1%) | - |
TK - ALK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| ALK | inactive (99.57%) | - |
| LTK | inactive (95.02%) | - |
TK - Axl
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| AXL | inactive (100.77%) | - |
| MER | inactive (113.77%) | - |
| TYRO3 | inactive (100.71%) | - |
TK - Src
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| BLK | inactive (100.05%) | - |
| BRK | inactive (98.72%) | - |
| SRC | inactive (108.84%) | - |
| FGR | inactive (94.73%) | - |
| FRK | inactive (105.78%) | - |
| FYN | inactive (110.36%) | - |
| HCK | inactive (89.54%) | - |
| LCK | inactive (86.3%) | - |
| SRM | inactive (92.93%) | - |
| YES | inactive (97.77%) | - |
| LYN | inactive (98.14%) | - |
TK - Tec
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| BMX | inactive (107.75%) | - |
| BTK | inactive (98.23%) | - |
| ITK | inactive (104.65%) | - |
| TEC | inactive (114.21%) | - |
| TXK | inactive (103.69%) | - |
TK - PDGFR
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| KIT | inactive (97.69%) | - |
| FLT3 | inactive (97.21%) | - |
| FMS | inactive (109.14%) | - |
| PDGFRb | inactive (62.76%) | - |
| PDGFRa | inactive (101.99%) | - |
TK - Csk
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| CSK | inactive (89.97%) | - |
| CTK | inactive (77.59%) | - |
TK - DDR
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| DDR2 | inactive (100.26%) | - |
TK - EGFR
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| EGFR | inactive (92.73%) | - |
| ErbB2 | inactive (105.56%) | - |
| ErbB4 | inactive (98.1%) | - |
TK - Eph
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| EphA1 | inactive (99.07%) | - |
| EphA2 | inactive (88.97%) | - |
| EphA3 | inactive (96.97%) | - |
| EphA4 | inactive (104.93%) | - |
| EphA5 | inactive (104.56%) | - |
| EphA6 | inactive (95%) | - |
| EphA7 | inactive (79.9%) | - |
| EphA8 | inactive (98.66%) | - |
| EphB1 | inactive (100.14%) | - |
| EphB2 | inactive (106.73%) | - |
| EphB3 | inactive (65.77%) | - |
| EphB4 | inactive (83.88%) | - |
TK - FAK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| FAK | inactive (98.9%) | - |
| PYK2 | inactive (101.68%) | - |
TK - Fer
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| FER | inactive (95.56%) | - |
| FES | inactive (99.03%) | - |
TK - FGFR
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| FGFR1 | inactive (99.02%) | - |
| FGFR2 | inactive (99.51%) | - |
| FGFR3 | inactive (90.17%) | - |
| FGFR4 | inactive (96.18%) | - |
TK - VEGFR
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| FLT1 | inactive (101.87%) | - |
| FLT4 | inactive (97.5%) | - |
| KDR | inactive (96.55%) | - |
TK - InsR
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| IGF1R | inactive (92.33%) | - |
| IRR | inactive (102.41%) | - |
| INSR | inactive (104.4%) | - |
TK - JakA
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| JAK1 | inactive (98.82%) | - |
| JAK2 | inactive (106.83%) | - |
| JAK3 | inactive (95.72%) | - |
| TYK2 | inactive (93.46%) | - |
TK - Musk
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| MUSK | inactive (101.9%) | - |
TK - Ret
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| RET | inactive (93.12%) | - |
TK - Met
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| RON | inactive (90.13%) | - |
| MET | inactive (89.43%) | - |
TK - Sev
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| ROS | inactive (95.02%) | - |
TK - Syk
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| SYK | inactive (109.95%) | - |
| ZAP70 | inactive (100.12%) | - |
TK - Tie
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| TIE2 | inactive (96.73%) | - |
TK - Trk
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| TRKA | inactive (96.26%) | - |
| TRKB | inactive (101.7%) | - |
| TRKC | inactive (95.87%) | - |
TKL
TKL - STKR
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| ALK1 | inactive (99.29%) | - |
| ALK2 | inactive (105.05%) | - |
| ALK4 | inactive (113.39%) | - |
| TGFbR1 | inactive (96.69%) | - |
| TGFbR2 | inactive (102.17%) | - |
TKL - RAF
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| ARAF | inactive (99.36%) | - |
| BRAF | inactive (94.06%) | - |
| RAF1 | inactive (97.53%) | - |
TKL - IRAK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| IRAK1 | inactive (94.2%) | - |
| IRAK4 | inactive (87.52%) | - |
TKL - LISK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| LIMK1 | inactive (98.51%) | - |
TKL - LRRK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| LRRK2 | inactive (82.03%) | - |
TKL - MLK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| MLK1 | inactive (112.25%) | - |
| MLK2 | inactive (104.16%) | - |
| MLK3 | inactive (104.89%) | - |
| TAK1 | inactive (104.72%) | - |
| ZAK | inactive (97.93%) | - |
TKL - RIPK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| RIPK2 | inactive (101.09%) | - |
CAMK
CAMK - CAMKL
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| NuaK1 | inactive (108.41%) | - |
| BRSK1 | inactive (94.15%) | - |
| BRSK2 | inactive (96.55%) | - |
| CHK1 | inactive (89.17%) | - |
| LKB1 | inactive (99.46%) | - |
| MARK1 | inactive (131.85%) | - |
| MARK3 | inactive (98.14%) | - |
| MARK4 | inactive (102.26%) | - |
| MELK | inactive (87.15%) | - |
| PASK | inactive (103.04%) | - |
| QIK | inactive (95.11%) | - |
| NuaK2 | inactive (98.72%) | - |
| MARK2 | inactive (130.96%) | - |
| AMPKa1 | - | - |
CAMK - CAMK1
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| CaMK1a | inactive (98.11%) | - |
| CaMK1b | inactive (108.06%) | - |
| CaMK1d | inactive (113.75%) | - |
| CaMK1g | inactive (108.33%) | - |
| CaMK4 | inactive (91.87%) | - |
CAMK - CAMK2
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| CaMK2a | inactive (90.95%) | - |
| CaMK2b | inactive (104.27%) | - |
| CaMK2d | inactive (87.25%) | - |
| CaMK2g | inactive (105.43%) | - |
CAMK - RAD53
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| CHK2 | inactive (97.64%) | - |
CAMK - DAPK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| DAPK1 | inactive (98.16%) | - |
| DAPK2 | inactive (86.77%) | - |
| DRAK1 | inactive (100.17%) | - |
| DAPK3 | inactive (107.03%) | - |
CAMK - DCAMKL
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| DCLK2 | inactive (97.48%) | - |
| DCLK1 | - | - |
CAMK - MAPKAPK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| MAPKAPK2 | inactive (98.9%) | - |
| MAPKAPK3 | inactive (99.05%) | - |
| MAPKAPK5 | inactive (93.38%) | - |
| MNK1 | inactive (91.43%) | - |
| MNK2 | inactive (100.81%) | - |
CAMK - MLCK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| smMLCK | inactive (101.08%) | - |
| skMLCK | inactive (100.8%) | - |
CAMK - PHK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| PHKg1 | inactive (92.04%) | - |
| PHKg2 | inactive (93.14%) | - |
CAMK - PIM
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| PIM1 | inactive (98.77%) | - |
| PIM2 | inactive (98.3%) | - |
| PIM3 | inactive (97.66%) | - |
CAMK - PKD
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| PKD1 | inactive (97.75%) | - |
| PKD3 | inactive (85.1%) | inactive (2511.89nM) |
| PKD2 | inactive (81.84%) | inactive (5011.87nM) |
CAMK - TSSK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| TSSK1 | inactive (83.02%) | - |
| TSSK2 | inactive (88.59%) | - |
CAMK - STK33
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| STK33 | inactive (93.97%) | - |
STE
STE - STE11
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| MAP3K5 | inactive (101.84%) | - |
| MAP3K2 | inactive (121.52%) | - |
| MAP3K3 | inactive (118.17%) | - |
STE - STE-Unique
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| COT | inactive (94.3%) | - |
| NIK | inactive (113.96%) | - |
STE - STE20
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| GCK | inactive (107.96%) | - |
| HGK | inactive (108.19%) | - |
| KHS1 | inactive (98.26%) | - |
| LOK | inactive (93.79%) | - |
| MINK | inactive (100.39%) | - |
| MST1 | inactive (100.52%) | - |
| MST2 | inactive (94.08%) | - |
| MST3 | inactive (105.33%) | - |
| MST4 | inactive (117.24%) | - |
| OSR1 | inactive (96.88%) | - |
| PAK1 | inactive (110.38%) | - |
| PAK2 | inactive (100.87%) | - |
| PAK3 | inactive (98.29%) | - |
| PAK4 | inactive (92.62%) | - |
| PAK5 | inactive (96.35%) | - |
| PAK6 | inactive (103.29%) | - |
| SLK | inactive (90.75%) | - |
| YSK1 | inactive (97.08%) | - |
| STLK3 | inactive (93.66%) | - |
| TAO1 | inactive (96.24%) | - |
| TAO2 | inactive (98.74%) | - |
| TAO3 | inactive (95.74%) | - |
| MYO3B | inactive (99.25%) | - |
STE - STE7
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| MAP2K1 | inactive (88.98%) | - |
| MAP2K2 | inactive (92.35%) | - |
| MAP2K6 | inactive (96.54%) | - |
Other
Other - Aur
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| AurA | inactive (86.43%) | - |
| AurB | inactive (91.27%) | - |
| AurC | inactive (83.76%) | - |
Other - CAMKK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| CaMKK1 | inactive (98.9%) | - |
| CaMKK2 | inactive (101.19%) | - |
Other - Haspin
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| Haspin | inactive (81.27%) | - |
Other - IKK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| IKKa | inactive (100.37%) | - |
| IKKb | inactive (94.85%) | - |
| IKKe | inactive (87.96%) | - |
| TBK1 | inactive (106.41%) | - |
Other - NEK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| NEK1 | inactive (69.61%) | - |
| NEK11 | inactive (92.86%) | - |
| NEK2 | inactive (108.75%) | - |
| NEK4 | inactive (103.56%) | - |
| NEK6 | inactive (90.48%) | - |
| NEK7 | inactive (90.11%) | - |
| NEK9 | inactive (104.44%) | - |
| NEK3 | inactive (96%) | - |
Other - TOPK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| PBK | inactive (110.3%) | - |
Other - PLK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| PLK1 | inactive (95.11%) | - |
| PLK2 | inactive (101.68%) | - |
| PLK3 | inactive (94.67%) | - |
| PLK4 | - | - |
Other - SgK496
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| SgK496 | inactive (100.68%) | - |
Other - NAK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| MPSK1 | inactive (100.23%) | - |
Other - TTK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| TTK | inactive (98.77%) | - |
Other - ULK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| ULK1 | inactive (103.57%) | - |
| ULK2 | inactive (100.83%) | - |
| ULK3 | inactive (101.14%) | - |
Other - WEE
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| Wee1 | inactive (100.97%) | - |
Other - WNK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| Wnk2 | inactive (96.42%) | - |
| Wnk3 | inactive (96.63%) | - |
Other - TLK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| TLK2 | inactive (95.75%) | - |
Other - CDC7
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| CDC7 | - | - |
CK1
CK1
| Test Member No. in Family |
|---|
| Family | no. Member on 518kinase | RBC | Metz |
|---|
| CK1 | 7 | 6 | 5 |
| VRK | 3 | 1 | - |
CK1 - CK1
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| CK1d | inactive (89.8%) | - |
| CK1g1 | inactive (102.38%) | - |
| CK1g2 | inactive (99.64%) | - |
| CK1g3 | inactive (103.46%) | - |
| CK1a | active (0%) | - |
| CK1e | inactive (98.19%) | - |
CK1 - VRK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| VRK1 | inactive (104.3%) | - |
CMGC
CMGC - CK2
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| CK2a1 | inactive (110.95%) | - |
| CK2a2 | inactive (108.53%) | - |
CMGC - CLK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| CLK1 | inactive (107.64%) | - |
| CLK2 | inactive (86.92%) | - |
| CLK3 | inactive (112.37%) | - |
| CLK4 | inactive (113.91%) | - |
CMGC - DYRK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| DYRK1A | inactive (98.74%) | - |
| DYRK1B | inactive (97.05%) | - |
| DYRK2 | inactive (101.75%) | - |
| DYRK3 | inactive (104.54%) | - |
| DYRK4 | inactive (96.26%) | - |
| HIPK1 | inactive (100.14%) | - |
| HIPK2 | inactive (100.41%) | - |
| HIPK3 | inactive (98.4%) | - |
| HIPK4 | inactive (90.47%) | - |
CMGC - MAPK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| Erk1 | inactive (95.22%) | - |
| Erk2 | inactive (85.72%) | - |
| JNK3 | inactive (98.43%) | - |
| NLK | active (15.78%) | - |
| p38a | active (5.23%) | - |
| p38b | active (22.32%) | - |
| p38d | inactive (93.95%) | - |
| p38g | inactive (92.09%) | - |
| JNK1 | inactive (100.35%) | - |
| JNK2 | inactive (93.53%) | - |
CMGC - GSK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| GSK3A | inactive (98.56%) | - |
| GSK3B | inactive (101.43%) | - |
CMGC - SRPK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| MSSK1 | inactive (105.01%) | - |
| SRPK1 | inactive (98.96%) | - |
| SRPK2 | - | - |
CMGC - CDK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| CDC2 | - | - |
| CDK2 | - | - |
| CDK5 | - | - |
| CDK8 | - | - |
| CDK7 | - | - |
| CDK9 | - | - |
| CDK11 | - | - |
Atypical
Atypical
| Test Member No. in Family |
|---|
| Family | no. Member on 518kinase | RBC | Metz |
|---|
| PDHK | 5 | 1 | - |
| Alpha | 6 | - | 1 |
Atypical - PDHK
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| PDHK1 | inactive (87.4%) | - |
Atypical - Alpha
| Bioactivity |
|---|
| Kinase | RBC | Metz |
|---|
| eEF2K | - | - |